As of March 2023, the National Stock Exchange traded around 7.3 million ADRs of Dr. Reddy's Laboratories. While nearly 4.8 million shares were traded at the New York Stock Exchange, and less than one million shares were traded in the Bombay Stock Exchange in that month.
Number of shares traded by Dr. Reddy's Laboratories Limited in financial year 2021 and 2023, by month (in millions)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2023
- Premium Statistic Dr. Reddy's Laboratories' net worth FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' EBITDA FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' PAT FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2017-2023, by product segment
- Premium Statistic Dr. Reddy's Laboratories' revenue from global generics 2022 by region
- Premium Statistic Dr. Reddy's Laboratories' return on capital employed FY 2013-2023
- Premium Statistic Aurobindo Pharma's net profit FY 2013-2023
About the region
10
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue share 2023, by market
- Premium Statistic Aurobindo Pharma's revenue from growth market formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's expenditure on R&D FY 2017-2022, by type
- Premium Statistic Aurobindo Pharma's revenue FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
Selected statistics
10
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
8
- Basic Statistic Top drugs based on projected 2024 global sales
- Basic Statistic Share value of the generic pharmaceuticals market in Estonia 2008-2022
- Premium Statistic Leading European pharmaceutical & biotechnology companies by market cap 2023
- Basic Statistic Share value of the generic pharmaceuticals market in Slovakia 2002-2021
- Basic Statistic Value share of generic pharmaceuticals market in Czechia 2011-2021
- Basic Statistic Share value of the generic pharmaceuticals market in Finland 2012-2021
- Premium Statistic Mexico: pharmaceutical production 2017-2022
- Basic Statistic Value of pharmaceutical sales in Belgium 2004-2022
Related statistics
10
- Premium Statistic Patented drugs revenue in prescribed drug market in India 2008-2015
- Premium Statistic Sun Pharma's income FY 2010-2023
- Premium Statistic Sun Pharma's profit after tax FY 2014-2023
- Premium Statistic Net profit of major pharma companies India 2024
- Premium Statistic R&D investments as part of sales by leading Indian pharma companies in FY 2012-2021
- Premium Statistic Indian pharmaceutical export value FY 2012-2024
- Premium Statistic Indian pharmaceutical export share FY 2020, by region
- Premium Statistic Annual revenue of Indian pharmaceutical market 2015-2030
- Premium Statistic MAT of therapies in Indian pharma 2022
- Premium Statistic Distribution of therapies in Indian pharmaceuticals 2022
Further related statistics
10
- Net profit of Midea Group FY 2012-FY 2022
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Sales of Nestlé in Zone North America (NA) from 2021-2023, by product categories
- Global sales of the Nestlé Group 2005-2023
- Nestlé Group's sales distribution worldwide 2023, by region
- EBIT margin of the Nestlé Group 2009-2023, by product category
- Sales of Nestlé in AOA 2021-2023, by product categories
- Pfizer's ad spending 2006-2023
- Global net earnings of the Brunswick Corporation 2007-2023
Further Content: You might find this interesting as well
Statistics
- Net profit of Midea Group FY 2012-FY 2022
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Sales of Nestlé in Zone North America (NA) from 2021-2023, by product categories
- Global sales of the Nestlé Group 2005-2023
- Nestlé Group's sales distribution worldwide 2023, by region
- EBIT margin of the Nestlé Group 2009-2023, by product category
- Sales of Nestlé in AOA 2021-2023, by product categories
- Pfizer's ad spending 2006-2023
- Global net earnings of the Brunswick Corporation 2007-2023
Dr. Reddy's Laboratories. (July 1, 2023). Number of shares traded by Dr. Reddy's Laboratories Limited in financial year 2021 and 2023, by month (in millions) [Graph]. In Statista. Retrieved March 29, 2024, from https://www.statista.com/statistics/991415/india-drreddy-s-laboratories-number-of-traded-shares/
Dr. Reddy's Laboratories. "Number of shares traded by Dr. Reddy's Laboratories Limited in financial year 2021 and 2023, by month (in millions)." Chart. July 1, 2023. Statista. Accessed March 29, 2024. https://www.statista.com/statistics/991415/india-drreddy-s-laboratories-number-of-traded-shares/
Dr. Reddy's Laboratories. (2023). Number of shares traded by Dr. Reddy's Laboratories Limited in financial year 2021 and 2023, by month (in millions). Statista. Statista Inc.. Accessed: March 29, 2024. https://www.statista.com/statistics/991415/india-drreddy-s-laboratories-number-of-traded-shares/
Dr. Reddy's Laboratories. "Number of Shares Traded by Dr. Reddy's Laboratories Limited in Financial Year 2021 and 2023, by Month (in Millions)." Statista, Statista Inc., 1 Jul 2023, https://www.statista.com/statistics/991415/india-drreddy-s-laboratories-number-of-traded-shares/
Dr. Reddy's Laboratories, Number of shares traded by Dr. Reddy's Laboratories Limited in financial year 2021 and 2023, by month (in millions) Statista, https://www.statista.com/statistics/991415/india-drreddy-s-laboratories-number-of-traded-shares/ (last visited March 29, 2024)
Number of shares traded by Dr. Reddy's Laboratories Limited in financial year 2021 and 2023, by month (in millions) [Graph], Dr. Reddy's Laboratories, July 1, 2023. [Online]. Available: https://www.statista.com/statistics/991415/india-drreddy-s-laboratories-number-of-traded-shares/